Format

Send to

Choose Destination
J Ethnopharmacol. 2012 Feb 15;139(3):879-82. doi: 10.1016/j.jep.2011.12.006. Epub 2011 Dec 19.

Ibogaine and the inhibition of acetylcholinesterase.

Author information

1
Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA. kra1@nyu.edu

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:

Ibogaine is a psychoactive monoterpine indole alkaloid extracted from the root bark of Tabernanthe iboga Baill. that is used globally in medical and nonmedical settings to treat drug and alcohol addiction, and is of interest as an ethnopharmacological prototype for experimental investigation and pharmaceutical development. The question of whether ibogaine inhibits acetylcholinesterase (AChE) is of pharmacological and toxicological significance.

MATERIALS AND METHODS:

AChE activity was evaluated utilizing reaction with Ellman's reagent with physostigmine as a control.

RESULTS:

Ibogaine inhibited AChE with an IC(50) of 520±40 μM.

CONCLUSIONS:

Ibogaine's inhibition of AChE is physiologically negligible, and does not appear to account for observations of functional effects in animals and humans that might otherwise suggest the possible involvement of pathways linked to muscarinic acetylcholine transmission.

PMID:
22200647
DOI:
10.1016/j.jep.2011.12.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center